Enterome Starts Phase I Clinical Trial With its Lead Candidate EB8018 to Treat Crohn's Disease

PARIS and CAMBRIDGE Massachusetts January 5 2017 PRNewswire EB8018 is a firstinclass oral small molecule targeting the hostmicrobiome interaction by blocking FimH ENTEROME SA a pioneer in the development of pharmaceuticals and diagnostics based ...